【光大研究每日速递】20260302

Group 1: Banking Sector - The self-discipline of interbank deposit rates has led to a decline, but high costs of interbank liabilities and switching between fixed and current deposits indicate a need for further regulation [5] - Future management of interbank deposit rates may impose upper limits on the proportion of current deposits priced above self-discipline and regulate fixed deposit rates [5] Group 2: Oil and Gas Industry - The escalation of geopolitical tensions in the Middle East, particularly the airstrikes by Israel and the US on Tehran, is expected to alleviate concerns over oil supply and demand, potentially driving up oil prices due to increased geopolitical risk premiums [6] - Long-term investment value in the oil and gas sector, including major state-owned enterprises and oil services, is emphasized [6] Group 3: Basic Chemicals - The strategic significance of phosphorus resources has increased, with the US government listing phosphorus and glyphosate as critical defense materials, suggesting a focus on leading companies with resource advantages and integrated industrial chains in the phosphorus fertilizer and chemical sectors [6] Group 4: Environmental Sector - The trend of Chinese Token going abroad is intensifying, with low electricity costs being a core advantage, and the development of power computing is progressing steadily [7] - The industry is expected to reach a cyclical bottom under marketization, with potential for valuation recovery following a reversal in expectations [7] Group 5: Renewable Energy and Environmental Protection - The value of power operators is expected to be reassessed in the context of Token going abroad, with advantages including low electricity costs leading to cheaper Token prices and the ability to provide cross-border services without exporting electricity [8] - The sector is seen as having opportunities for valuation recovery due to low valuations at the cyclical bottom and the potential for economic growth and acceptance of new applications [8] Group 6: Pharmaceutical Sector - The pharmaceutical sector is expected to recover, with a reaffirmation of the investment thesis based on clinical value [8] - Recent performance indicates that the A-share pharmaceutical index underperformed compared to broader indices, suggesting potential for future recovery [8]